An NMR-based metabolomic approach to investigate the effects of supplementation with glutamic acid in piglets challenged with deoxynivalenol

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Wu, Miaomiao ^a,b   Xiao, Hao ^a,b   Ren, Wenkai ^a,b   Yin, Jie ^a,b   Hu, Jiayu ^a,b   Duan, Jielin ^a,b   Liu, Gang ^a   Tan, Bie ^a   Xiong, Xia ^a   Oso, Abimbola Oladele ^c   Adeola, Olayiwola ^d   Yao, Kang ^b   Yin, Yulong ^a   Li, Tiejun ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c Department of Animal Physiology   (Nigeria)

^d PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALANINE; ARGININE; CASPASE 3; CHOLINE; CITRIC ACID; CREATININE; CYCLINE; FUMARIC ACID; GLUTAMIC ACID; GLUTATHIONE PEROXIDASE; GLYCINE; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN; LACTIC ACID; LOW DENSITY LIPOPROTEIN; PROLINE; SUPEROXIDE DISMUTASE; TRIMETHYLAMINE OXIDE; UNSATURATED FATTY ACID; UREA; VOMITOXIN; TRICHOTHECENE DERIVATIVE;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; DIET SUPPLEMENTATION; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ILEUM; JEJUNUM; LIPID METABOLISM; METABOLOMICS; NONHUMAN; OXIDATIVE STRESS; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL; ANIMAL; BLOOD; CYTOLOGY; DIETARY SUPPLEMENT; DRUG EFFECTS; FOOD CONTAMINATION; INTESTINE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PIG;

SUIDAE;

ANIMALS; CASPASE 3; CELL PROLIFERATION; DIETARY SUPPLEMENTS; FOOD CONTAMINATION; GLUTAMIC ACID; GLUTATHIONE PEROXIDASE; INTESTINES; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; SUPEROXIDE DISMUTASE; SWINE; TRICHOTHECENES;

EID: 84917696434     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113687     Document Type: Article

References (58)

1. Pestka JJ (2010) Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance. Archives of Toxicology 84: 663-679.
2. Schollenberger M, Jara HT, Suchy S, Drochner W, Muller HM (2002) Fusarium toxins in wheat flour collected in an area in southwest Germany. International Journal of Food Microbiology 72: 85-89.
3. He P, Young LG, Forsberg C (1993) Microbially Detoxified Vomitoxin-Contaminated Corn for Young-Pigs. Journal of Animal Science 71: 963-967.
4. Awad WA, Ghareeb K, Bohm J, Zentek J (2010) Decontamination and detoxification strategies for the Fusarium mycotoxin deoxynivalenol in animal feed and the effectiveness of microbial biodegradation. Food Additives and Contaminants Part a-Chemistry Analysis Control Exposure & Risk Assessment 27: 510-520.
5. Volkl A, Vogler B, Schollenberger M, Karlovsky P (2004) Microbial detoxification of mycotoxin deoxynivalenol. Journal of Basic Microbiology 44: 147-156.
6. Wu M, Xiao H, Ren W, Yin J, Tan B, et al. (2014) Therapeutic effects of glutamic Acid in piglets challenged with deoxynivalenol. PLoS One 9: e100591.
7. Young VR, Ajami AM (2000) Glutamate: an amino acid of particular distinction. J Nutr 130: 892S-900S.
8. Reeds PJ, Burrin DG, Stoll B, Jahoor F (2000) Intestinal glutamate metabolism. Journal of Nutrition 130:978s-982s.
9. Gabriel AS, Uneyama H (2013) Amino acid sensing in the gastrointestinal tract. Amino Acids 45: 451-461.
10. Geng M, Li T, Kong X, Song X, Chu W, et al. (2011) Reduced expression of intestinal N-acetylglutamate synthase in suckling piglets: a novel molecular mechanism for arginine as a nutritionally essential amino acid for neonates. Amino Acids 40: 1513-1522.
11. Wu GY, Fang YZ, Yang S, Lupton JR, Turner ND (2004) Glutathione metabolism and its implications for health. Journal of Nutrition 134: 489-492.
12. He Q, Kong X, Wu G, Ren P, Tang H, et al. (2009) Metabolomic analysis of the response of growing pigs to dietary L-arginine supplementation. Amino Acids 37: 199-208.
13. Nicholson JK, Holmes E, Lindon JC, Wilson ID (2004) The challenges of modeling mammalian biocomplexity. Nat Biotechnol 22: 1268-1274.
14. Nicholson JK, Wilson ID (2003) Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2: 668-676.
15. Yin Y, Yao K, Liu Z, Gong M, Ruan Z, et al. (2010) Supplementing L-leucine to a low-protein diet increases tissue protein synthesis in weanling pigs. Amino Acids 39: 1477-1486.
16. Prelusky DB, Gerdes RG, Underhill KL, Rotter BA, Jui PY, et al. (1994) Effects of low-level dietary deoxynivalenol on haematological and clinical parameters of the pig. Nat Toxins 2: 97-104.
17. Xu MH, Deng CS, Zhu YQ, Lin J (2003) Role of inducible nitric oxide synthase expression in aberrant crypt foci-adenoma-carcinoma sequence. World Journal of Gastroenterology 9: 1246-1250.
18. He QH, Ren PP, Kong XF, Wu YN, Wu GY, et al. (2012) Comparison of serum metabolite compositions between obese and lean growing pigs using an NMR-based metabonomic approach. Journal of Nutritional Biochemistry 23: 133-139.
19. Xiao H, Wu MM, Tan BE, Yin YL, Li TJ, et al. (2013) Effects of composite antimicrobial peptides in weanling piglets challenged with deoxynivalenol: I. Growth performance, immune function, and antioxidation capacity. Journal of Animal Science 91: 4772-4780.
20. Xiao H, Tan BE, Wu MM, Yin YL, Li TJ, et al. (2013) Effects of composite antimicrobial peptides in weanling piglets challenged with deoxynivalenol: II. Intestinal morphology and function. Journal of Animal Science 91: 4750-4756.
21. Chipuk JE, Green DR (2006) Dissecting p53-dependent apoptosis. Cell Death and Differentiation 13: 994-1002.
22. Nicholson JK, Lindon JC, Holmes E (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29: 1181-1189.
23. Nicholson JK, Lindon JC (2008) Systems biology - Metabonomics. Nature 455: 1054-1056.
24. Constantinou MA, Papakonstantinou E, Benaki D, Spraul M, Shulpis K, et al. (2004) Application of nuclear magnetic resonance spectroscopy combined with principal component analysis in detecting inborn errors of metabolism using blood spots: a metabonomic approach. Analytica Chimica Acta 511:303-312.
25. Williams R, Lenz EM, Wilson AJ, Granger J, Wilson ID, et al. (2006) A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats. Mol Biosyst 2: 174-183.
26. Zhang XY, Wang YL, Hao FH, Zhou XH, Han XY, et al. (2009) Human Serum Metabonomic Analysis Reveals Progression Axes for Glucose Intolerance and Insulin Resistance Statuses. Journal of Proteome Research 8: 5188-5195.
27. Guan S, Gong M, Yin YL, Huang RL, Ruan Z, et al. (2011) Occurrence of mycotoxins in feeds and feed ingredients in China. Journal of Food Agriculture & Environment 9: 163-167.
28. Binder EM, Tan LM, Chin LJ, Handl J, Richard J (2007) Worldwide occurrence of mycotoxins in commodities, feeds and feed ingredients. Animal Feed Science and Technology 137: 265-282.
29. Diesing AK, Nossol C, Panther P, Walk N, Post A, et al. (2011) Mycotoxin deoxynivalenol (DON) mediates biphasic cellular response in intestinal porcine epithelial cell lines IPEC-1 and IPEC-J2. Toxicology Letters 200: 8-18.
30. Yin J, Ren W, Duan J, Wu L, Chen S, et al. (2014) Dietary arginine supplementation enhances intestinal expression of SLC7A7 and SLC7A1 and ameliorates growth depression in mycotoxin-challenged pigs. Amino Acids 46: 883-892.
31. Halawa A, Danicke S, Kersten S, Breves G (2013) Intestinal transport of deoxynivalenol across porcine small intestines. Archives of Animal Nutrition 67: 134-146.
32. Dinu D, Bodea GO, Ceapa CD, Munteanu MC, Roming FI, et al. (2011) Adapted response of the antioxidant defense system to oxidative stress induced by deoxynivalenol in Hek-293 cells. Toxicon 57: 1023-1032.
33. Kouadio JH, Mobio TA, Baudrimont I, Moukha S, Dano SD, et al. (2005) Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2. Toxicology 213: 56-65.
34. Sahu SC, O'Donnell MW, Wiesenfeld PL (2010) Comparative hepatotoxicity of deoxynivalenol in rat, mouse and human liver cells in culture. Journal of Applied Toxicology 30: 566-573.
35. Blachier F, Boutry C, Bos C, Tome D (2009) Metabolism and functions of L-glutamate in the epithelial cells of the small and large intestines. American Journal of Clinical Nutrition 90: 814s-821s.
36. Bracarense APFL, Lucioli J, Grenier B, Pacheco GD, Moll WD, et al. (2012) Chronic ingestion of deoxynivalenol and fumonisin, alone or in interaction, induces morphological and immunological changes in the intestine of piglets. British Journal of Nutrition 107: 1776-1786.
37. Kelman Z (1997) PCNA: structure, functions and interactions. Oncogene 14: 629-640.
38. Strzalka W, Ziemienowicz A (2011) Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation. Ann Bot 107: 1127-1140.
39. Guo D, Bi H, Liu B, Wu Q, Wang D, et al. (2013) Reactive oxygen species-induced cytotoxic effects of zinc oxide nanoparticles in rat retinal ganglion cells. Toxicol In Vitro 27: 731-738.
40. Pestka JJ, Smolinski AT (2005) Deoxynivalenol: Toxicology and potential effects on humans. Journal of Toxicology and Environmental Health-Part B-Critical Reviews 8: 39-69.
41. Bensassi F, El Golli-Bennour E, Abid-Essefi S, Bouaziz C, Hajlaoui MR, et al. (2009) Pathway of deoxynivalenol-induced apoptosis in human colon carcinoma cells. Toxicology 264: 104-109.
42. Boutry C, Matsumoto H, Bos C, Moinard C, Cynober L, et al. (2012) Decreased glutamate, glutamine and citrulline concentrations in plasma and muscle in endotoxemia cannot be reversed by glutamate or glutamine supplementation: a primary intestinal defect? Amino Acids 43: 1485-1498.
43. Crenn P, Messing B, Cynober L (2008) Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clinical Nutrition 27: 328-339.
44. Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, et al. (2003) Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 124: 1210-1219.
45. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B (2000) Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 119: 1496-1505.
46. Rhoads JM, Plunkett E, Galanko J, Lichtman S, Taylor L, et al. (2005) Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome. J Pediatr 146: 542-547.
47. Mihaleva VV, van Schalkwijk DB, de Graaf AA, van Duynhoven J, van Dorsten FA, et al. (2014) A systematic approach to obtain validated partial least square models for predicting lipoprotein subclasses from serum NMR spectra. Anal Chem 86: 543-550.
48. El Harchaoui K, van der Steeg WA, Stroes ESG, Kuivenhoven JA, Otvos JD, et al. (2007) Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women - The EPIC-Norfolk Prospective Population study. Journal of the American College of Cardiology 49: 547-553.
49. Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, et al. (2003) Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52: 453-462.
50. Saxena V, Gupta A, Gowda GAN, Saxena R, Yachha SK, et al. (2006) H-1 NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure. Nmr in Biomedicine 19: 521-526.
51. Serkova N, Fuller TF, Klawitter J, Freise CE, Niemann CU (2005) H-1-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney International 67: 1142-1151.
52. Hauet T, Gibelin H, Richer JP, Godart C, Eugene M, et al. (2000) Influence of retrieval conditions on renal medulla injury: Evaluation by proton NMR spectroscopy in an isolated perfused pig kidney model. Journal of Surgical Research 93: 1-8.
53. Rezzi S, Ramadan Z, Fay LB, Kochhar S (2007) Nutritional metabonomics: Applications and perspectives. Journal of Proteome Research 6: 513-525.
54. Foxall PJD, Lenz EM, Lindon JC, Neild GH, Wilson ID, et al. (1996) Nuclear magnetic resonance and high-performance liquid chromatography nuclear magnetic resonance studies on the toxicity and metabolism of ifosfamide. Therapeutic Drug Monitoring 18: 498-505.
55. Griffin JL (2003) Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. Current Opinion in Chemical Biology 7: 648-654.
56. Cole E, Naimark D, Aprile M, Wade J, Cattran D, et al. (1995) An Analysis of Predictors of Long-Term Cadaveric Renal-Allograft Survival. Clinical Transplantation 9: 282-288.
57. Sugita Y, Takao K, Toyama Y, Shirahata A (2007) Enhancement of intestinal absorption of macromolecules by spermine in rats. Amino Acids 33: 253-260.
58. Cornell HJ, Stelmasiak T (2007) A unified hypothesis of coeliac disease with implications for management of patients. Amino Acids 33: 43-49.